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(10 -6 M) caused a further reduction in the percentage of proliferating cells.
Immunocytochemical analysis showed that all the examined compounds gave a statistically significant reduction in the percentage of cells with a positive reaction to PCNA and Ki 67 antigen. TGF-b 1 , isotretinoin and tretinoin added to the culture resulted in the lowest percentage of PCNA positive cells. However, the lowest fraction of Ki 67 positive cells was observed after addition of isotretinoin. The obtained results also confirm the fact that the well-known regulatory proteins Bcl-2 and p53 play an important role in the regulation of apoptosis in the MCF-7 cell line, with lowered Bcl-2 expression accompanying easier apoptotic induction. The majority of the examined compounds act via the p53 pathway although some bypass this important proapoptotic factor.
Retinoic acid controls cell differentiation, proliferation and carcinogenesis. The mechanism of its action is based mainly on the activation of RAR and RXR receptors (Chambon, 1995) and on the action of CRBP I and CRABP II proteins, which are involved in retinoid autoregulation (Smith et al., 1991; Durand et al., 1992) . The RAR and RXR receptors share sequence homology with other members of the steroid receptor superfamily, such as estrogen or vitamin A receptors. Retinoids complexed to their receptor can activate or repress transcription from retinoic acid response elements in the promoters of retinoid-sensitive genes. It is known that RARs and RXRs can form homodimers or heterodimers and RXRs heterodimerize with multiple members of the steroid receptor superfamily. This heterodimerization plays an important role in the regulation of the nuclear receptor-dependent signaling pathways.
The mechanism of retinoid-induced cell death is not yet well understood. Apoptosis can be induced in a number of human cancer cell lines, including breast cancer cells . The mechanisms likely to stimulate apoptosis include p21 induction Liu et al., 1996) , AP-1 complex induction (Schadendorf et al., 1996) , suppression of Bcl-2 expression and/or TGF-b induction , and IGF-3 induction (Gucev et al., 1996) . The expression of RAR and ER (estrogen receptors) is highly correlated in breast cancer, and the growth of many ER(+) breast cancer cell lines is arrested by retinoic acid. Moreover, retinoic acid can also induce apoptosis in breast cancer cells (Nagy et al., 1995) . It was shown that in the ER(+) MCF-7 cell line retinoid acid decreases the Bcl-2 level (Gross et al., 1999) and down-regulates cyclin D1 and CDK2 protein levels and kinase activity (Teixeira & Pratt, 1997) . On the other hand, expression of cyclin D1 sensitizes ER(+) breast cancer cells to retinoic acid-induced mitochondrial death pathway through Bax activity, cytochrom c release and caspase-9 cleavage (Niu et al., 2001) . The effect of retinoic acid in the cell is regulated by peptide growth factors, with the major role played by the TGF-b family. Practically all cells have functional receptors for these peptides, which explains their unique regulatory role both in physiological and pathological processes (Sporn & Roberts, 1991) . Mammals have three known TGF-b isoforms, defined as TGF-b-1, -2 and -3 (Barnard et al., 1990; . In in vitro conditions, the major role of the TGF-b cytokines is to inhibit the growth of epithelial cells and thus they can strongly affect the growth of many neoplasms of epithelial origin (Reiss & Barcellos-Hoff, 1997) . In carcinogenesis, they play a dual role depending on the response of neoplastic cells to these polypeptides. Transformable cells are sensitive to TGF-b-dependent arrest of the cell cycle. In the early phase of carcinogenesis TGF-b play a suppressive function and are able to affect the reaction of antiestrogens and retinoids. However, during the neoplastic process, when the population of transformable cells consists of TGF-b-resistant mutated cells, an environment rich in bioactive TGF-b selectively promotes the expression of these cells (Reiss, 1999) . It has been shown that this can be related to specific genetic changes (Markowitz et al., 1995) and defects of receptors for TGF-b (Birchenall- Roberts et al., 1995; Kim et al., 1997) .
As summarized above, the TGF-b family modulates the action of retinoids. Since neoplasm treatment is still a problem, new ways of potential treatment in oncological therapeutic schemes are badly needed. The aim of the study was to investigate whether exogenous TGF-b 1 and retinoids can affect the response of the human breast cancer MCF-7 cell-line to estradiol and tamoxifen. Effective neoplastic therapy involves also the apoptosis pathway induction in cancer cells and thus it appears important to search for pro-and antiapoptotic factors regulating this process. In the present study exogenous TGF-b 1 at 0.003-30 ng/ml showed antiproliferative activity. Simultaneous addition of TGF-b 1 and estradiol caused a statistically significant reduction in the percentage of proliferating cells. For the increasing concentrations of TGF-b 1 , 3 and 30 ng/ml, and estradiol at 10 -8 M, it was 112.2 ± 6.5% and 84.6 ± 6.8% compared to the 123.5 ± 6.4% in the 10 -8 M estradiol group (P < 0.05), whereas for 0.3, 3 and 30 ng/ml TGF-b 1 and 10 -9 M estradiol it was 112.3 ± 9.7%, 106.1 ± 6.5% and 40.7 ± 5.4%, compared to the 189.2 ± 62.6% in the 10 -9 M estradiol group (P < 0.05) (Fig. 1) .
MATERIALS AND METHODS

Materials
Moreover, only 30 ng/ml TGF-b 1 in combination with tamoxifen (10 -7 or 10 -6 M) caused a statistically significant reduction in the percentage of proliferating cells to 38.2 ± 6.7% and 33.6 ± 6.9%, respectively, compared to the 86.8 ± 28.8% in 10 -7 M tamoxifen group and 51.1 ± 4.0% in 10 -6 M tamoxifen group (P < 0.05) (Fig. 2) . isotretinoin was the lowest concentration showing an inhibitory effect (35.2 ± 18.8%, P < 0.05), (Figs. 4, 6 ).
Determination of the expression of PCNA, Ki 67, Bcl-2 and p53 antigens in MCF-7 cells
Following a 24-h culture of MCF-7 cells in the presence of TGF-b 1 or isotretinoin, the percentage of PCNA-positive cells was the lowest, compared to control (35.7 ± 3.7% and 38.7 ± 3.2%). Combination of the examined compounds with TGF-b 1 did not cause further reduction.
The exposure of the culture to isotretinoin resulted in a reduction in the percentage of Ki 67-positive cells to 38.7 ± 2.9%, i.e., the lowest value (Table 1) .
The incubation of the MCF-7 cells in the presence of any of the examined compounds alone or in combinations caused a distinct and statistically significant decrease in the percentage of Bcl-2 positive cells (Table 1 ).
The percentage of p53 positive cells was the highest when both isotretinoin and TGF-b 1 were simultaneously added to the culture (Table 1).
Determination of the apoptotic index
The highest percentage of apoptotic cells was obtained in media containing isotretinoin and a combination of isotretinoin with TGF-b 1 (35.9 ± 4.5% and 33.0 ± 2.3%). Only 12.0 ± 4.9% were found to be apoptotic after culture supplementation with TGF-b 1 alone (Table 2) .
DISCUSSION
The TGF-b cytokines affect a number of cell functions, including proliferation, differentiation, migration and adhesion (Massaque et al., 1992) , via type I and II receptors (TGF-bRI and TGF-bRII), which belong to a large family of receptor serine/threonine kinases (Attisan et al., 1990) . TGF-b inhibits pro- liferation of epithelial cells, including neoplastic ones (Kalkhoven et al., 1995) , although this effect is sometimes dominated by promotion of oncogenes and induction of carcinogenes (Pierce et al., 1995) . In hormone sensitive breast neoplasms growth factors and steroid hormones are released and co-operate in complex regulation of cell functions. The action of TGF-b in cell culture depends on the type of cells, general conditions of the culture and the presence of other polypeptide growth factors (Desruisseau et al., 1996; Hietanen et al., 1998; Cupp et al., 1999; Hishikawa et al., 1999) . The MCF-7 cells produce the receptor proteins TGF-bI and TGF-bII (Jakowlew et al., 1997) , and hence exogenous TGF-b 1 can inhibit proliferation of these cells in a dose-dependent manner (Lafon et al., 1995) ten times more efficiently than TGF-b 2 (Arric et al., 1990) . It was shown that exogenous TGF-b 1 at 0.1-1.0 ng/ml inhibited proliferation of epithelial neoplasms of the vagina (Hietanen et al., 1998) . When added to a culture of human prostatic cancer cells, it inhibited proliferation in 40% (Desruisseau et al., 1996) . Although early studies of Karey et al. (1988) did not confirm a significant effect of exogenous TGF-b 1 at £ 20.0 mg/ml on MCF-7 cell culture (Karey & Sirbascu, 1988) , we found an inhibitory effect of this cytokine on the incorporation of [ 3 H]thymidine and proliferation of the examined cell line. Sun et al. (1994) reported that a low level of expression of TGF-bRI or TGF-bRII may limit the response of neoplastic cells to exogenous TGF-b (Sun et al., 1994) , and in the case of TGF-b 1 , this depends on a decrease in type II receptor expression (Liu et al., 2000) . According to Liu et al. (2000) the sensitivity of MCF-7 cells to exogenous TGF-b 1 may also depend on the number of passages.
It has been proven that the antiproliferative action of TGF-b 1 does not block the activity of estrogen receptors (Perry et al., 1995; Stoica et al., 1997) , but inhibits the proliferation of TGF-b 1 35.7 ± 3.7 P < 0.0001 67.5 ± 1.7 P < 0.0001 6.7 ± 1.8 P < 0.0005 40.5 ± 2.3 P < 0.0001 Isotretinoin 38.7 ± 3.2 P < 0.0001 38.7 ± 2.9 P < 0.0001
40.2 ± 2.5 P < 0.0001
64.2 ± 3.7 P < 0.0003
16.0 ± 2.1 P < 0.02 50.5 ± 3.1 P < 0.0001
49.7 ± 2.1 P < 0.0001 10.3 ± 3.0 P < 0.001
28.1 ± 3.1 n.s. 58.2 ± 1.7 P < 0.004 66.3 ± 3.1 P < 0.0001 5.9 ± 0.7 P < 0.0003 41.2 ± 2.0 P < 0.0001 3´10 -5 M isotretinoin, 3´10 -5 M tretinoin, TGF-b 1 (3 ng/ml) and 10 -5 M tamoxifen; exposure time 24 h. Data presented as mean values ± S.D. (n = 4); statistically significant differences relative to the control group; n.s., statistically not significant. Table 1 . Percentage of PCNA, Ki 67, Bcl-2 and p53 positive MCF-7 breast carcinoma cells MCF-7 cells through inhibition of the cell cycle in phase G 1 . This is due to a decrease in the activity of Cdk2 kinase without Cdk protein modification and cyclin expression, and is correlated with an increase in the accumulation of p21WAF in the cell nucleus .
We observed a significant decrease in the stimulatory effect of estradiol in the presence of TGF-b 1 , although the findings of Stewart et al. (1992) suggested that exogenous TGF-b added to the culture only slightly reduced the estradiol-induced growth of cell line MCF-7. While tamoxifen used in a pharmacological dose effectively inhibited MCF-7-cell proliferation (Perry et al., 1995) , it had no significant effect in the presence of TGF-b 1 at or below 3 ng/ml.
Retinoids and SERM's (selective estrogen receptor modulators) are the most widely used factors in chemoprevention and treatment of neoplastic diseases. It has been shown that retinoids, like tamoxifen, increase the production and activation of TGF-b in cell cultures (Knabbe et al., 1987; Glick et al., 1989; Colletta et al., 1990; Koli et al., 1997) , including breast cancer cell lines, and that their chemopreventive action in vitro occurs via local activation of TGF-b. The antiestrogens and retinoids (all-trans retinoic acid) can reverse (via a TGF-b mediated pathway) the repressing effect of estrogen on AIB1 gene expression in the cell line MCF-7. This may be of significance in cancer progression (Lauritsen et al., 2002) . In vivo studies, however, demonstrated no significant effect of tamoxifen and 9-cis retinoic acid on the expression of TGF-b in mammary ductal epithelium or periductal stroma (Zujewski et al., 2001) , although Beenken et al. (2002) suggested that the TGF cytokines take part in the protective effect of 13-cis retinoic acid in dysplastic oral leukoplakia. Our previously published findings confirmed the inhibitory effect of the examined retinoids in vitro on the proliferation of breast cancer MCF-7 cells in a dose-dependent manner (Czeczuga-Semeniuk et al., 2001) . The cytokines (IFN-a, INF-g, TNF-a, TGF-b, INF-b) used in experimental cultures of various transformed cell lines differ in their antiproliferative action (Frey et al., 1991; Bollag et al., 1992; Coradini et al., 1997) . In the presence of retinoids, TGF-b and TNF-a inhibit MCF-7 cell proliferation most effectively, causing a (n = 4); statistically significant differences relative to the control group; n.s., statistically not significant. synergistic effect (Bollag et al., 1992) . In our study, it was shown that TGF-b 1 with low concentrations of retinoid were the most effective combination and exogenous TGF-b 1 only increased the antiproliferative effect of low tretinoin concentrations, which may play a role in the regulation of MCF-7 cell growth. In the study of Bollag et al. (1992) , statistically significant inhibition of proliferation was observed after simultaneous application of TGF-b 1 at 3 ng/ml and tretinoin at 3´10 Estrogens can control cell proliferation through an effect on TGF-b receptor expression (Massaque et al., 1992) . Estradiol stimulates growth of hormone sensitive breast cancers mainly through the reduction in TGF-b 2 and TGF-b 3 mRNA expression, but does not affect TGF-b 1 mRNA expression (Arric et al., 1990; Jeng et al., 1993) . Addition of 17-bestradiol to the culture containing exogenous TGF-b 1 and retinoids had a significant effect on inhibition of proliferation of breast cancer MCF-7 cells mainly at high concentrations of retinoids. Since retinoids, unlike estradiol, increase the expression of TGF-b 1 and TGF-b 2 (Cupp et al., 1999) , their addition to the culture may promote the action of exogenous TGF-b 1 .
Although tamoxifen increased the expression of TGF-b receptors in the MCF-7 cell line (Koli et al., 1997) and secretion of the respective proteins (Knabbe et al., 1987) , and when added to the culture medium caused a fourfold increase in TGF-b 1 activity (Chen et al., 1996) , we observed its inhibitory effect in the presence of TGF-b 1 and low concentrations of isotretinoin and threefold higher concentration of tretinoin. Retinoic acid can also induce secretion and activation of TGF-b 1 or TGF-b 2 by epithelial cells (Glick et al., 1989; Danielpour, 1996) . It seems interesting that in the presence of 3´10 -4 M tretinoin, both estradiol and tamoxifen increased proliferation to 95%. Apoptosis can be induced by a number of factors, and its regulation in neoplastic cells is still not fully elucidated. It has been shown based on the MCF-7 cell model that retinoids can induce programmed cell death (Toma et al., 1997; Mangiarotti et al., 1998; CzeczugaSemeniuk et al., 2001; Niu et al., 2001) . TGF-b behaves in a similar way, but the reaction is partly mediated by CTGF (Hishikawa et al., 1999) . The effect of tamoxifen on this process may occur through the secretion of active TGF-b (Chen et al., 1996) . We observed the largest number of cells with morphological features typical of apoptosis, i.e., condensation and fragmentation of chromatin and cytoplasm vacuolization, after application of isotretinoin alone or in combination with exogenous TGF-b 1 . However, in case of the combination of isotretinoin with TGF-b 1 , the over twofold increase in the percentage of Bcl-2-positive cells is difficult to explain, since of all cell proteins Bcl-2 can most strongly inhibit apoptosis induced by numerous physiological and pathological factors (Boise et al., 1993) . The lack of a significant increase in p53 expression in MCF-7 cells in the presence of tretinoin and tamoxifen may suggest that p53 does not take part in the apoptotic pathway induced by these factors.
TGF-b 1 affects diverse cellular processes and its action can be modified by hormones and other growth factors involved in proliferation, differentiation and apoptosis. Also, a crosstalk between epithelial cells and stromal fibroblasts of the mammary gland should be considered. Our findings are difficult to interpret, but they seem to suggest that the examined compounds used in combination may be more effective in the treatment of breast cancer than monotherapy. The increased efficacy may be due to retinoic acid ability to modulate angiogenesis in the tumor microenvironment through downregulation of TGF-b 1 secretion (Liss et al., 2002) and indi- Vol. 51 TGF-b 1 , retinoids, estradiol and antiestrogens in breast cancer cellscate that the loss of cell response to retinoids and TGF-b may play a role in cancer progression (Hietanen et al. 1998 ).
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